ADVERTISEMENT
News
Bronchodilator Recalled
04/03/2020
Recalled are 100-count bottles (NDC 29033-001-01) from lot THE190501 (Exp. 11/22), which were distributed in Tennessee and Missouri.
Nostrum Laboratories voluntarily initiated the recall March 6, 2020. On March 25, 2020, the FDA designated the recall Class II, communicating use of the drug may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Theophylline is a prescription bronchodilator used to treat asthma, emphysema, and chronic bronchitis.
—Jolynn Tumolo